@xconomy.com 4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@techcrunch.com 4 years ago
Lucence raises $20 million Series A for its non-invasive cancer screening technology
@techcrunch.com 4 years ago
Verily, Alphabet’s other money-making, non-Google business, partners with Color on genetic analysis
@techcrunch.com 5 years ago
Biotech AI startup Sight Diagnostics gets $27.8M to speed up blood tests
@engadget.com 5 years ago
Eyelid glucose sensor might pick up where Verily left off
@techcrunch.com 5 years ago
Sight Diagnostics starts selling an AI-based diagnostics device for faster blood tests
@venturebeat.com 6 years ago
Zebra shifts business model to AI that saves lives at scale